Versant Ventures

23.08.2024 • News

Novartis and Versant Launch Borealis Biosciences

Novartis announced it has partnered with Versant Ventures to form Borealis Biosciences, an independent, discovery-stage biotechnology company based in Vancouver, Canada, focused on developing next-generation xRNA-based medicines for kidney diseases.

05.06.2018 • News

Digitization’s Impact on the Pharmaceutical Industry

Top-Feature

Nova-Institut GmbH

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Bio-Rad Laboratories

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Evonik Operations GmbH (Hanau)

Biobased Feedstocks as a Roadmap to Defossilization

Interview

Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Novartis International AG

Bayer AG - Pharmaceuticals Communications & Health Policy